{
  "registry_schema": "nmd-vcell-cell-context-registry/1.0",
  "interface_build": "EA-20260817-57",
  "resource_release": "v1.2.0-measured-dmd-evidence",
  "evidence_freeze": "2026-08-03",
  "score_policy": "No scalar context-readiness score is computed.",
  "counts": {
    "context_records": 10,
    "diseases": 4,
    "observed_or_measured_contexts": 9,
    "required_outcome_missing_contexts": 1,
    "required_truth_missing_contexts": 1,
    "direct_dmd_candidate_perturbation_outcomes": 0
  },
  "records": [
    {
      "context_id": "CTX-DMD-MYOGENIC-CORRECTION",
      "disease": "DMD",
      "context": "Myogenic induction / DMD-locus correction",
      "evidence_state": "MEASURED_CORRECTION_REFERENCE",
      "coverage_group": "observed",
      "source_dataset": "GSE272233",
      "unit_structure": "Biological repeat / sample; 3 repeats per group",
      "observed_result": "21 samples; 24 background-specific dual-supported reversal pathways; 0 strict reversals shared across all 3 backgrounds.",
      "permitted_use": "DMD induction and locus-correction reference",
      "claim_ceiling": "No candidate-gene response prediction",
      "href": "/resource/measured-dmd-evidence/",
      "statistical_unit": "Biological repeat / sample; 3 repeats per group"
    },
    {
      "context_id": "CTX-DMD-PATIENT-MUSCLE",
      "disease": "DMD",
      "context": "Patient skeletal muscle",
      "evidence_state": "MEASURED_DISEASE_REFERENCE",
      "coverage_group": "observed",
      "source_dataset": "PRJNA772047",
      "unit_structure": "Independent patient sample / pathway-level pseudobulk analysis",
      "observed_result": "291 sample-level DMD disease pathways supported by CAMERA in the external patient-muscle reference.",
      "permitted_use": "External disease-pathway replication",
      "claim_ceiling": "No candidate-gene perturbation efficacy",
      "href": "/resource/measured-dmd-evidence/",
      "statistical_unit": "Independent patient sample / pathway-level pseudobulk analysis"
    },
    {
      "context_id": "CTX-DMD-CANDIDATE-PERTURBATION",
      "disease": "DMD",
      "context": "Candidate perturbation in DMD muscle",
      "evidence_state": "MISSING_REQUIRED_OUTCOME",
      "coverage_group": "missing",
      "source_dataset": null,
      "unit_structure": "Required matched DMD/control biological repeats",
      "observed_result": "0/21 candidates have an independent perturbation outcome in a DMD muscle model.",
      "permitted_use": "Study design and predictability gating only",
      "claim_ceiling": "Prediction locked; absence is not a negative effect",
      "href": "/resource/prediction_readiness",
      "statistical_unit": "Required matched DMD/control biological repeats"
    },
    {
      "context_id": "CTX-FSHD-PATIENT-MYOTUBE",
      "disease": "FSHD",
      "context": "Patient myotube nuclei",
      "evidence_state": "MEASURED_DESCRIPTIVE",
      "coverage_group": "observed",
      "source_dataset": "GSE143452",
      "unit_structure": "8 samples from 1 FSHD2 and 1 control donor",
      "observed_result": "32,273 nuclei; all 17 requested DUX4-axis genes detected; donor-general prevalence is not estimable.",
      "permitted_use": "Descriptive state stratification",
      "claim_ceiling": "No donor-general or patient treatment estimate",
      "href": "/resource/disease/fshd/",
      "statistical_unit": "8 samples from 1 FSHD2 and 1 control donor"
    },
    {
      "context_id": "CTX-FSHD-IDUX4",
      "disease": "FSHD",
      "context": "Inducible DUX4 myoblast time course",
      "evidence_state": "INDUCED_CELL_LINE_RESPONSE",
      "coverage_group": "observed",
      "source_dataset": "GSE205421",
      "unit_structure": "4 culture wells per condition across 6 conditions",
      "observed_result": "24 samples; 6,986 genes significant at 14 h using q < 0.05 and |log2FC| ≥ 1.",
      "permitted_use": "DUX4-response timing and experiment design",
      "claim_ceiling": "Cell-line response, not patient therapeutic efficacy",
      "href": "/resource/disease/fshd/",
      "statistical_unit": "4 culture wells per condition across 6 conditions"
    },
    {
      "context_id": "CTX-DM1-ISOGENIC-MYOBLAST",
      "disease": "DM1",
      "context": "Isogenic repeat-corrected myoblast",
      "evidence_state": "MEASURED_CORRECTION_REFERENCE",
      "coverage_group": "observed",
      "source_dataset": "GSE127296",
      "unit_structure": "Independently derived clone; clone identity retained",
      "observed_result": "8 clones; 163 differential splicing events at FDR < 0.05; clone effects remain a stated boundary.",
      "permitted_use": "Expression and splicing correction reference",
      "claim_ceiling": "Clones are not independent patients",
      "href": "/resource/disease/dm1/",
      "statistical_unit": "Independently derived clone; clone identity retained"
    },
    {
      "context_id": "CTX-DM1-PATIENT-MUSCLE",
      "disease": "DM1",
      "context": "Patient skeletal muscle",
      "evidence_state": "MEASURED_DISEASE_REFERENCE",
      "coverage_group": "observed",
      "source_dataset": "GSE201255",
      "unit_structure": "Independent biopsy; repeat biopsies excluded",
      "observed_result": "36 genes overlap the isogenic and patient splicing signals; global expression alignment is negligible (Spearman ρ = -0.039).",
      "permitted_use": "Patient expression/splicing comparison",
      "claim_ceiling": "No prognosis or treatment ranking",
      "href": "/resource/disease/dm1/",
      "statistical_unit": "Independent biopsy; repeat biopsies excluded"
    },
    {
      "context_id": "CTX-SMA-SPINAL-ORGANOID",
      "disease": "SMA",
      "context": "Spinal organoid / ASO response",
      "evidence_state": "MEASURED_INTERVENTION_REFERENCE",
      "coverage_group": "observed",
      "source_dataset": "GSE290979 / GSE290980",
      "unit_structure": "Donor-derived line after technical aggregation",
      "observed_result": "31 samples from 3 control, 2 SMA and 2 ASO-treated SMA lines; no global gene-expression reversal.",
      "permitted_use": "Human neural intervention-response design",
      "claim_ceiling": "No patient motor-outcome prediction",
      "href": "/resource/disease/sma/",
      "statistical_unit": "Donor-derived line after technical aggregation"
    },
    {
      "context_id": "CTX-SMA-TREATED-MUSCLE",
      "disease": "SMA",
      "context": "Treated patient skeletal muscle",
      "evidence_state": "MEASURED_RESIDUAL_REFERENCE",
      "coverage_group": "observed",
      "source_dataset": "GSE252128",
      "unit_structure": "Independent biopsy",
      "observed_result": "8 treated SMA versus 7 control samples; 0 genes at q < 0.05 and |log2FC| ≥ 0.5; residual-module q-values exceed 0.30.",
      "permitted_use": "Residual muscle-module experiment design",
      "claim_ceiling": "Null threshold result is not proof of full correction",
      "href": "/resource/disease/sma/",
      "statistical_unit": "Independent biopsy"
    },
    {
      "context_id": "CTX-SMA-NEURONAL",
      "disease": "SMA",
      "context": "Motor and cortical neurons",
      "evidence_state": "MEASURED_DISEASE_REFERENCE",
      "coverage_group": "observed",
      "source_dataset": "GSE302774",
      "unit_structure": "Independent culture replicate; n = 3 per condition and context",
      "observed_result": "KIF5A decreased concordantly in both neuronal contexts (log2FC approximately -1.31 in each).",
      "permitted_use": "Cross-neuronal disease-context comparison",
      "claim_ceiling": "No calibrated intervention or patient response",
      "href": "/resource/disease/sma/",
      "statistical_unit": "Independent culture replicate; n = 3 per condition and context"
    }
  ],
  "claim_boundary": "Context records summarize released measurements and explicit missing target-context outcome. They do not create a calibrated perturbation response, therapeutic ranking, patient trajectory or clinical recommendation."
}
